Business Description
SciBase Holding AB
ISIN : SE0029277631
Total Employee Number:
49Compare
Compare
Traded in other countries / regions
SCIB.Sweden5J3.Germany IPO Date
2020-08-06Description
SciBase Holding AB is a medical technology company specializing in early detection of skin cancer and prevention in dermatology. SciBase develops, manufactures, and commercializes Nevisense, a point-of-care technology platform that combines AI (artificial intelligence) and EIS technology to elevate diagnostic accuracy and support the prevention of skin diseases. The company's product portfolio consists of the Nevisense platform technology for multiple clinical applications and proprietary Nevisense electrodes. The products are based on measurements using electrical impedance spectroscopy (EIS), analysed using custom artificial intelligence (AI)-based algorithms. The company operates in two segments, which include skin cancer and skin barrier assessment.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.98 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | -0.31 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -8.06 | |||||
Beneish M-Score | -3.32 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.8 | |||||
3-Year EBITDA Growth Rate | 25.6 | |||||
3-Year EPS without NRI Growth Rate | 26.8 | |||||
3-Year FCF Growth Rate | 28.2 | |||||
3-Year Book Growth Rate | -64.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 54.75 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 31.91 | |||||
9-Day RSI | 44.04 | |||||
14-Day RSI | 49.66 | |||||
3-1 Month Momentum % | 30.16 | |||||
6-1 Month Momentum % | 8100 | |||||
12-1 Month Momentum % | 115.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.15 | |||||
Quick Ratio | 3.74 | |||||
Cash Ratio | 2.99 | |||||
Days Inventory | 171.82 | |||||
Days Sales Outstanding | 95.41 | |||||
Days Payable | 116.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -80.4 | |||||
Shareholder Yield % | -37.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.64 | |||||
Operating Margin % | -198.96 | |||||
Net Margin % | -207.51 | |||||
EBITDA Margin % | -168.34 | |||||
FCF Margin % | -185.51 | |||||
OCF Margin % | -185.51 | |||||
ROE % | -274.29 | |||||
ROA % | -147.5 | |||||
ROIC % | -393.17 | |||||
3-Year ROIIC % | 838.77 | |||||
ROC (Joel Greenblatt) % | -1177.69 | |||||
ROCE % | -177.31 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 3.88 | |||||
PB Ratio | 5.89 | |||||
Price-to-Tangible-Book | 5.86 | |||||
EV-to-EBIT | -3.51 | |||||
EV-to-EBITDA | -3.51 | |||||
EV-to-Revenue | 5.91 | |||||
EV-to-FCF | -3.47 | |||||
Price-to-GF-Value | 1.55 | |||||
Price-to-Median-PS-Value | 0.43 | |||||
| Price-to-Net-Current-Asset-Value | 6.56 | |||||
| Price-to-Net-Cash | 13.67 | |||||
Earnings Yield (Greenblatt) % | -28.49 | |||||
FCF Yield % | -26.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SciBase Holding AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4.21 | ||
| EPS (TTM) (€) | -1.722 | ||
| Beta | -91.8631 | ||
| 3-Year Sharpe Ratio | 0.6 | ||
| 3-Year Sortino Ratio | 12.55 | ||
| Volatility % | 3906.11 | ||
| 14-Day RSI | 49.66 | ||
| 14-Day ATR (€) | 0.006783 | ||
| 20-Day SMA (€) | 1.64 | ||
| 12-1 Month Momentum % | 115.79 | ||
| 52-Week Range (€) | 0.02 - 4.22 | ||
| Shares Outstanding (Mil) | 10.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SciBase Holding AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SciBase Holding AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-12 | In 105 days | ||
| Second quarter earnings results for 2026 | 2026-08-19 | In 20 days | ||
| 0.01:1 Stock Split | 2026-06-04 | 1.64 (+0.00%) | ||
| General meeting for 2026 | 2026-05-19 10:00 | 1.84 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 1.28 (+0.00%) | ||
| Annual report for 2025 | 2026-04-27 | 1.28 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-24 | 0.02 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-07 | 0.30 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-19 | 0.80 (+0.00%) | ||
| General meeting for 2025 | 2025-06-17 10:00 | 0.94 (+0.00%) |
Show
Entries
SciBase Holding AB Frequently Asked Questions
What is SciBase Holding AB(FRA:5J3)'s stock price today?
The current price of FRA:5J3 is €1.64. The 52 week high of FRA:5J3 is €4.22 and 52 week low is €0.02.
When is next earnings date of SciBase Holding AB(FRA:5J3)?
The next earnings date of SciBase Holding AB(FRA:5J3) is 2026-08-19.
Does SciBase Holding AB(FRA:5J3) pay dividends? If so, how much?
SciBase Holding AB(FRA:5J3) does not pay dividend.
Press Release
Articles on SciBase Holding AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers